Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy

JOURNAL ARTICLE published September 2022 in JCO Precision Oncology

Authors: Pat W. Whitworth | Peter D. Beitsch | Mary K. Murray | Paul D. Richards | Angela Mislowsky | Carrie L. Dul | James V. Pellicane | Paul L. Baron | Rakhshanda Layeequr Rahman | Laura A. Lee | Beth B. Dupree | Pond R. Kelemen | Andrew Y. Ashikari | Raye J. Budway | Cristina Lopez-Penalver | William Dooley | Shiyu Wang | Patricia Dauer | Andrea R. Menicucci | Erin B. Yoder | Christine Finn | Lisa E. Blumencranz | William Audeh